Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
桂龙丹颗粒
- Development stage
- Unknown
- Lead developer
- Gui Long Pharmaceutical
- Administration
- Oral
01
Overview
桂龙丹颗粒 (Guilongdan Granules), also known as Pink Granules, is a Traditional Chinese Medicine (TCM) formulation manufactured by GuiLong Pharmaceutical Anhui Co., Ltd. It is composed of a blend of traditional Chinese medicinal herbs, including Astragalus, Chinese angelica, red peony root, Ligusticum chuanxiong, peach kernel, safflower, fructus aurantii, platycodon, Achyranthes bidentata, Ophiopogon japonicus, and Radix Trichosanthis. This combination of herbs is traditionally used to invigorate blood, dispel blood stasis, tonify Qi and blood, regulate Qi, clear heat, and moisten dryness. It is administered orally.
- Other names
- Pink Granules
02
Targets
EGFR (Epidermal growth factor receptor)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)PIK3CA (Phosphoinositide 3-kinase alpha)
Beyond the preview
Go deeper on 桂龙丹颗粒.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 桂龙丹颗粒.